Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg

Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg / Aldinucci, A; Rizzo, R; Bonechi, E; Fainardi, E; Bortolotti, D; Mariottini, A; Mechi, C; Repice, AM; Massacesi, L; Ballerini, C. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - STAMPA. - 25:(2018), pp. 350-350.

Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg

Aldinucci, A;Bonechi, E;Fainardi, E;BORTOLOTTI, DANIELE;Mariottini, A;Mechi, C;Repice, AM;Massacesi, L;Ballerini, C
2018

Abstract

Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg
2018
Aldinucci, A; Rizzo, R; Bonechi, E; Fainardi, E; Bortolotti, D; Mariottini, A; Mechi, C; Repice, AM; Massacesi, L; Ballerini, C
1c - Abstract su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1177423
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact